| nr | titel | auteur | datum  |
|---|
| 6.07.4.60/54 |  177Lu productie met de SHINE technologie | Antonia Denkova, Robin de Kruijff, B.Wolterbeek |
maart 2022 |
| 6.07.4.60/55 | Medical isotope production using local cyclotrons - A comparative study between Denmark and the Netherlands
| Technopolis group |
januari 2022 |
| 6.07.4.60/53 | Co-ordinated Approach to the Development and Supply of Radionuclides in the EU | N. Mario, A. Kolmayer, G. Turquet, A. Vallée, P.E. Goethals, NucAdvisor |
oktober 2021 |
| 6.07.4.60/51 | Study on sustainable and resilient supply of medical radioisotopes in the EU. Therapeutic Radionuclides | Joint Research Centre, A. Ligtvoet, C. Scholten, A. Davé, King, Petrosova, Chiti, Goulart De Medeiros, Joerger, Technopolis Group |
september 2021 |
| 6.07.4.60/50 | Innovatie in medische isotopenproductie zonder kernreactor | Laka, H.vd Keur |
februari 2021 |
| 6.07.4.60/49 | Leveringszekerheid voor medische radionucliden - aanvullingen 2020 | Roobol, Rosenbaum, de Waard, RIVM |
december 2020 |
| 6.07.4.60/42 | Marktontwikkeling en leveringszekerheid
voor medische radionucliden, aanvulling | Roobol, de Waard, RIVM |
september 2019 |
| 6.07.4.60/41 | Marktontwikkeling en leveringszekerheid voor medische radionucliden
| Roobol, de Waard, RIVM |
juli 2019 |
| 6.07.4.60/56 | European Study on Medical, Industrial and Research Applications of Nuclear and Radiation Technology | NucAdvisor, Technopolis, A. Kolmayer, N. Mario, A. Ligtvoet, J.Van Barnevald, C. Scholten, A. Davé |
juli 2019 |
| 6.07.4.60/48 | The Supply of Medical Isotopes. An Economic Diagnosis and Possible Solutions | OECD, NEA |
2019 |
| 6.07.4.60/46 | European Research Reactor Position Paper. Scenario for sustainable Molybdenum-99 production in Europe | CEA, NCBJ, NRG, PALLAS, RCR, SCK•CEN, TUM |
juni 2018 |
| 6.07.4.60/38 | Marktontwikkeling en leveringszekerheid voor medische isotopen | Roobol, de Waard, RIVM |
april 2018 |
| 6.07.4.60/52 | Opportunities and Approaches for Supplying Molybdenum-99 and Associated Medical Isotopes to Global Markets
| National Academy |
2018 |
| 6.07.4.60/37 | Medical isotopes. Global importance and opportunities for the Netherlands in a European context
| Nucleair Nederland |
november 2017 |
| 6.07.4.60/40 | Medical isotope production using Lighthouse accelerator | J.W.Blokker |
november 2017 |
| 6.07.4.60/30 | Productie en gebruik van medische radio-isotopen
in Nederland - Huidige situatie en toekomstverkenning | RIVM, Roobol, van der Reijden, de Waard–Schalk, Bijwaard |
juli 2017 |
| 6.07.4.60/31 | Cyclotron Based Production of Technetium-99m | IAEA |
juni 2017 |
| 6.07.4.60/29 | 2017 Medical Isotope Supply Review: Mo/Tc Market Demand and Production Capacity Projection 2017-2022 | OECD, NEA |
april 2017 |
| 6.07.4.60/33 | Medische isotopen. Belang voor de wereld en kansen voor Nederland | Nucleair Nederland |
april 2017 |
| 6.07.4.60/27 | Molybdenum-99 for Medical Imaging | National Academies of Sciences |
september 2016 |
| 6.07.4.60/28 | Ruwe schets van de problemen voor de behandeling van Nederlandse patiënten bij een plotselinge productiestop van medische isotopen in Nederland | RIVM, Smetsers, Bijwaard, Roobol |
juli 2016 |
| 6.07.4.60/36 | 2016 Medical Isotope Supply Review | NEA |
juni 2016 |
| 6.07.4.60/45 | Emissions from Fission-Based Medical Isotope Production and their Effects on the International Monitoring System | Th.W.Bowyer |
mei 2015 |
| 6.07.4.60/32 | Feasibility of Producing Molybdenum-99 on a Small Scale Using Fission of Low Enriched Uranium or Neutron Activation of Natural Molybdenum | IAEA |
januari 2015 |
| 6.07.4.60/25 | Future Supply of Medical Radioisotopes for the UK Report 2014 | British Nuclear Medicine Society, Science & Technology Facilities Council |
november 2014 |
| 6.07.4.60/24 | Nuclear Medicine without Nuclear Reactors or Uranium Enrichment | AAAS, Updegraff, Hoedl |
mei 2013 |
| 6.07.4.60/23 | The Supply of Medical Radioisotopes. Implementation of the HLG-MR Policy Approach. Results from a Self-assessment by the Global 99Mo/99mTc Supply Chain | OECD, NEA |
maart 2013 |
| 6.07.4.60/44 | Maximum reasonable radioxenon releases from medical isotope production facilities and their effect on monitoring nuclear explosions | Th.W.Bowyer, R.kephart, P.W.Eslinger, J.Friese |
september 2012 |
| 6.07.4.60/21 | Working materials Consultancy on Conversion planning for Mo-99 Production facilities from HEU to LEU | IAEA |
augustus 2010 |
| 6.07.4.60/43 | Isotopic noble gas signatures released from medical isotope production facilities- Simulations and measurements | P.Saey, Th.W.Bowyer, A.Ringbom |
april 2010 |
